Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
SRPT:NASDAQ
Sarepta Therapeutics Inc
21,49 US$
+2,92%
(+0,61) 1D
21,38 US$
-0,51% (-0,11)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRPT...
Açın
20,93 US$
High
21,66 US$
Low
20,92 US$
Mkt. cap
2,27 mlrd
Avg. vol.
3,11 mln
Volume
2,43 mln
52-wk high
64,80 US$
52-wk low
10,42 US$
EPS
-7,13 US$
Beta
0,29
Shares outstanding
104,99 mln
No. of employees
835
News stories
From sources across the web
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc
CEODouglas S. Ingram
Employees835
Founded1980
Headquarters-
Sector-
Websitesarepta.com
Last report
25 fev 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-3,58/ (-0,77 est.)USD
-365,29%miss
Revenue / Estimate
442,93 mln/ (390,95 mln est.)USD
+13,30%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
744,86 mln
611,09 mln
399,36 mln
442,93 mln
Cost of goods sold
911,01 mln
356,95 mln
369,66 mln
724,04 mln
Cost of revenue
911,01 mln
356,95 mln
369,66 mln
724,04 mln
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133,63 mln
137,90 mln
91,89 mln
128,30 mln
Operating expense
134,23 mln
138,56 mln
92,57 mln
128,97 mln
Total operating expenses
1,05 mlrd
495,51 mln
462,24 mln
853,02 mln
Operating income
-300,39 mln
115,58 mln
-62,88 mln
-410,08 mln
Other non operating income
-329,00K
-573,00K
-702,00K
-338,00K
EBT including unusual items
-383,52 mln
153,64 mln
-194,05 mln
-278,30 mln
EBT excluding unusual items
-295,03 mln
115,03 mln
-63,90 mln
-423,20 mln
Income tax expense
63,99 mln
-43,25 mln
-14,10 mln
4,55 mln
Effective tax rate
-16,68%
-28,15%
7,27%
-1,64%
Other operating expenses
-
-
-
-
Net income
-447,51 mln
196,89 mln
-179,95 mln
-282,85 mln
Net profit margin
-60,08%
32,22%
-45,06%
-63,86%
Earnings per share
-3,42
2,02
-0,13
-3,58
Interest and investment income
10,19 mln
5,25 mln
7,25 mln
8,07 mln
Interest expense
-4,50 mln
-5,23 mln
-7,56 mln
-20,84 mln
Net interest expenses
5,69 mln
26,00K
-316,00K
-12,77 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-290,41 mln
126,42 mln
-44,43 mln
-404,83 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer